René Russo

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

XLO

Current role

CEO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Xilio Therapeutics, Inc. (XLO)	Pharm.D. President and Chief Executive Officer	$643,700	$128,740	—	$5,293,319	$371,736	$14,000	$6,451,495
2024	Xilio Therapeutics, Inc. (XLO)	Pharm.D. President and Chief Executive Officer	$613,947	—	$97,350	$391,761	$337,671	$14,000	$1,454,729

No earnings-call appearances or filed executive changes recorded yet.